日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PD-1 inhibitor-induced rheumatic, endocrine, and sarcoidosis-like immune-related adverse events in metastatic melanoma are associated with improved survival and lower corticosteroid exposure

PD-1抑制剂诱发的转移性黑色素瘤患者的风湿性、内分泌性和结节病样免疫相关不良事件与生存期延长和皮质类固醇暴露量降低相关。

Lindén, Maria; Al Remawi, Hifaa; Fager, Anna; Akyürek, Levent M; Rudin, Anna; Ny, Lars; Bjursten, Sara; Pandita, Ankur; Levin, Max

Immune-related hepatitis and hypophysitis are associated with superior survival in melanoma patients treated with combined ipilimumab and nivolumab

免疫相关性肝炎和垂体炎与接受伊匹木单抗和纳武单抗联合治疗的黑色素瘤患者的生存率提高相关。

Al Remawi, Hifaa; Lindén, Maria; Zhao, Zhiyuan; Pandita, Ankur; Rudin, Anna; Ny, Lars; Bjursten, Sara; Levin, Max

Concentrations of S100B and neurofilament light chain in blood as biomarkers for checkpoint inhibitor-induced CNS inflammation

血液中S100B和神经丝轻链的浓度可作为检查点抑制剂诱导的中枢神经系统炎症的生物标志物

Bjursten, Sara; Zhao, Zhiyuan; Al Remawi, Hifaa; Studahl, Marie; Pandita, Ankur; Simrén, Joel; Zetterberg, Henrik; Lundell, Anna-Carin; Rudin, Anna; Ny, Lars; Levin, Max